Abstract:Both the primary tumor volume and the Ki-67 labeling index (LI) are prognostic factors for clinical outcome. We previously found a linear relationship between the metabolic ratio (Cho/Cr) and the Ki-67 LI1. In this study we investigated the relationship between the temporal change in the tumor volume and metabolic ratios of astrocytic brain tumors using magnetic resonance spectroscopy (MRS) during radiation therapy (RT). Twelve healthy male Sprague-Dawley rats were used and C6 tumor cells were injected into the right caudate nuclei of the rats. Tumor model was created successfully until tumors grew for 18 days after the injection. MRS was performed with 2-D multi-voxel PRESS sequence using a GE Signa VH/i 3.0T MR scanner equipped with rat-special coil. RT was given at the 19th day with dose of 4Gy in one single fraction. The metabolic information was obtained through image examinations performed before RT, and on the 4th, 10th, 14th, and 20th days after treatment, respectively. GE Functool software package was used for post-processing of spectrum. Pearson correlations were performed to check the relationship between tumor volume change and metabolic ratios. The metabolic information included choline-containing components (Cho), creatine and creatine phosphate (Cr), N-acetyl aspartate (NAA), lipid and lactate (LL) levels, and glutamate plus glutamine (Glx). It was interesting to find that the correlation between metabolic ratios of serial MRS with the tumor volume varied with time after RT. As shown in the Table 1, NAA/Cr, Lip/Cr and Lip1.3/Cr were significantly correlated with tumor volume before RT and the strong correlation remained until the 10th day after RT and again on the 20th day after RT. Cho/Cr was significantly correlated with tumor volume on the 4th, 10th and 20th day after RT. Cho/NAA became significantly correlated with tumor volume on the 20th day after RT. Glx/Cr was significantly correlated with tumor volume on the 4th and 14th day after RT. MI/Cr only correlated with tumor volume on the 10thday after RT. All metabolic ratios would provide useful information and could be prognostic factors depending on which stage the tumor regression is.Poster Viewing Abstracts 2167; Table 1Correlation between metabolites and volume at different timesp-valueCorrelated with volume at different time pointsBefore RT4th day after RT10th day after RT14th day after RT20th day after RTCho/Cr0.1480.0400.0410.1270.025Cho/NAA0.1970.4880.4150.7540.010NAA/Cr0.0190.0340.0200.1990.222Lip/Cr0.0010.0210.0100.9960.021Lip1.3/Cr0.0010.0080.00030.0630.516Glx/Cr0.4350.0420.1820.0040.420MI/Cr0.4270.2150.0270.0890.5131Yu TG, Feng Y, Feng XY, Dai JZ, Qian HJ, Huang Z. Prognostic factor from MR spectroscopy in rat with astrocytic tumor during radiation therapy. Br J Radiol 2015;88:20140418. Open table in a new tab

Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas

Predicting Tumor Recurrence Of Astrocytoma By Ki-67 And Proton Magnetic Resonance Spectra

Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma

~1H-MRS study on radiation-induced injury of the brain in early acute reaction stage after nasopharyngeal carcinoma radiotherapy

Correlation Between Metabolic Information and Tumor Volume for Astrocytic Brain Tumors Before and During Radiation Therapy

Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy

Prognostic Factor from MR Spectroscopy in Rat with Astrocytic Tumour During Radiation Therapy.

Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling

Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning

Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients

Nimg-56. Magnetic Resonance Spectroscopy In The Post-Treatment Metabolic Characterization Of Brain Tumors Of Glial Origin Of Central Nervous System

Metabolic Approach for Tumor Delineation in Glioma Surgery: 3d Mr Spectroscopy Image-Guided Resection

Five-Year Longitudinal MRI Follow-up and (1)H Single Voxel MRS in 14 Patients with Gliomatosis Treated with Temodal, Radiotherapy and Antiangiogenic Therapy.

Postoperative Perfusion Magnetic Resonance Imaging as a Tool for Predicting Survival in Glioblastoma of the Brain

1H-MR spectroscopy in grading of cerebral glioma: A new view point, MRS image quality assessment

Long-term Brain Tissue Monitoring after Semi-brain Irradiation in Rats Using Proton Magnetic Resonance Spectroscopy: A Preliminary Study in Vivo.

Significance of MR Spectroscopy in the Classification of Intracranial Astrocytic Tumors

Study of 1H-Magnetic Resonance Spectroscopy in the Peritumoral Edema of Astrocytomas in Brain

Application Of Magnetic Resonance Spectroscopy In The Preoperative Grading Of Gliomas

1H Magnetic Resonance Spectroscopy (1H MRS) in the Initially Differentiating Recurrent Brain Gliomas after Radiation Therapy from Delayed Cerebral Necrosis

The Relationship Between Cho/Naa and Glioma Metabolism: Implementation for Margin Delineation of Cerebral Gliomas